DETAILED NOTES ON DO-264

quinupristin/dalfopristin will raise the stage or outcome of ivacaftor by influencing hepatic/intestinal enzyme CYP3A4 metabolism.quinupristin/dalfopristin will enhance the amount or outcome of gepirone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Closely. Minimize gepirone dose by 50% when applied concomitantly wh